Novo Nordisk's weight loss drug Wegovy is now cheaper for even more patients
Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half ...
Hosted on MSN19d
Novo Nordisk slashing price of Wegovy to $499 a month to uninsured following rival’s move
The Food and Drug Administration in February removed Wegovy from its shortage list and told compounders to cease selling their cheaper copies in the coming months, having removed Zepbound in December.